Literature DB >> 11971094

Orthostatic hypotension from sympathetic denervation in Parkinson's disease.

D S Goldstein1, C S Holmes, R Dendi, S R Bruce, S-T Li.   

Abstract

BACKGROUND: Patients with PD often have signs or symptoms of autonomic failure, including orthostatic hypotension. Cardiac sympathetic denervation occurs frequently in PD, but this has been thought to occur independently of autonomic failure.
METHODS: Forty-one patients with PD (18 with and 23 without orthostatic hypotension) and 16 age-matched healthy volunteers underwent PET scanning to visualize sympathetic innervation after injection of 6-[(18)F]fluorodopamine. Beat-to-beat blood pressure responses to the Valsalva maneuver were used to identify sympathetic neurocirculatory failure and plasma norepinephrine to indicate overall sympathetic innervation.
RESULTS: All patients with PD and orthostatic hypotension had abnormal blood pressure responses to the Valsalva maneuver and septal and lateral ventricular myocardial concentrations of 6-[(18)F]fluorodopamine-derived radioactivity >2 SD below the normal mean. In contrast, only 6 of the 23 patients without orthostatic hypotension had abnormal Valsalva responses (p < 0.0001 compared with patients with orthostatic hypotension), and only 11 had diffusely decreased 6-[(18)F]fluorodopamine-derived radioactivity in the left ventricular myocardium (p = 0.0004). Of the 12 remaining patients without orthostatic hypotension, 7 had locally decreased myocardial radioactivity. Supine plasma norepinephrine was lower in patients with than in those without orthostatic hypotension (1.40 +/- 0.15 vs 2.32 +/- 0.26 nmol/L, p = 0.005). 6-[(18)F]fluorodopamine-derived radioactivity was less not only in the myocardium but also in the thyroid and renal cortex of patients with PD than in healthy control subjects.
CONCLUSIONS: In PD, orthostatic hypotension reflects sympathetic neurocirculatory failure from generalized sympathetic denervation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11971094     DOI: 10.1212/wnl.58.8.1247

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  68 in total

1.  Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy?

Authors:  Rupam Borgohain; Rukmini Mridula Kandadai; Afshan Jabeen; Meena A Kannikannan
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

2.  Treatment of dysautonomia in extrapyramidal disorders.

Authors:  Tjalf Ziemssen; Heinz Reichmann
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

3.  Central dopamine deficiency in pure autonomic failure.

Authors:  David S Goldstein; Courtney Holmes; Takuya Sato; Miya Bernson; Neptune Mizrahi; Richard Imrich; Gilberto Carmona; Yehonatan Sharabi; Alexander O Vortmeyer
Journal:  Clin Auton Res       Date:  2008-04       Impact factor: 4.435

4.  Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson's disease.

Authors:  K Hamada; M Hirayama; H Watanabe; R Kobayashi; H Ito; T Ieda; Y Koike; G Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

Review 5.  The pathology roadmap in Parkinson disease.

Authors:  D James Surmeier; David Sulzer
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

Review 6.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

7.  Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension.

Authors:  Yehonatan Sharabi; Richard Imrich; Courtney Holmes; Sandra Pechnik; David S Goldstein
Journal:  Mov Disord       Date:  2008-09-15       Impact factor: 10.338

8.  [Medical treatment of Parkinson's disease in elderly and multimorbid patients].

Authors:  I Lettow; J Röther
Journal:  Internist (Berl)       Date:  2014-06       Impact factor: 0.743

9.  Pattern of cardiac sympathetic denervation in idiopathic Parkinson disease studied with 11C hydroxyephedrine PET.

Authors:  Ka Kit Wong; David M Raffel; Robert A Koeppe; Kirk A Frey; Nicolaas I Bohnen; Sid Gilman
Journal:  Radiology       Date:  2012-07-27       Impact factor: 11.105

10.  Treadmill gait training improves baroreflex sensitivity in Parkinson's disease.

Authors:  Mohan Ganesan; Pramod Kumar Pal; Anupam Gupta; Talakad N Sathyaprabha
Journal:  Clin Auton Res       Date:  2014-06       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.